Jan. 17 at 10:00 AM
$NFLX Oversold on the 1YR Daily and 3YR Weekly Charts, approaching historical support line at
$82 (appx) with ER scheduled next week. The WBD deal has been largely seen as a negative; however, this is still an incredibly strong, dominant Company with excellent margins (EBITDA~29%, NM~24%) at 15% YoY top line growth (5YR CAGR 11%), excellent leverage (Net Debt/EBITDA~0.6, EBIT/INT~17, D/E~0.7),
$9.0B in Cash/ST and still room to grow globally with pricing power. I started my position here yesterday (1/16) ahead of earnings. Look for transient push down to
$82, 25-50% upside from this level (IMO).